3 Important Things to Know About AI Giant Anthropic Ahead of Its Possible November IPO

Anthropic is reportedly targeting a November IPO that could raise up to $100 billion at a $2 trillion valuation, potentially making it the largest public listing in history. The company expects annualized revenue run rate to exceed $110 billion by end-2026, up from $9 billion at end-2025, although estimated actual 2026 revenue of about $60 billion implies a richer 33x sales valuation. Growth is offset by substantial fixed compute commitments, including $15 billion annually through May 2029 for SpaceX data-center capacity and a six-year, $44.6 billion Nscale cloud agreement, increasing downside risk if sales growth slows.

Analysis

The key underwriting issue is not top-line velocity but conversion of contracted demand into durable gross profit after inference, training, and customer-acquisition costs. A premium valuation would require investors to treat run-rate demand as recurring software revenue despite potentially material usage variability, model-price deflation, and customer concentration. Any evidence that enterprise contracts are consumption-based, cancellable, or supported by credits would materially reduce the quality of the revenue base and likely compress the eventual post-IPO multiple.

NVDA is a second-order beneficiary only if the AI lab’s compute commitments translate into incremental GPU purchases rather than capacity reallocation by hosting partners. The more important near-term read-through may be negative for AI infrastructure multiples: an exceptionally large offering could absorb speculative AI capital and force public names to justify FCF conversion, especially companies with long-duration capex stories. Cloud lessors and GPU-hosting peers would face asymmetric downside if the issuer’s fixed capacity obligations become a public benchmark for uneconomic compute spending.

The proposed valuation creates a narrow execution corridor over the first 1-3 months after listing. Strong disclosed gross-margin progression, backlog quality, and remaining-performance-obligation growth could support scarcity-driven upside; any deceleration in quarterly revenue, increase in compute-cost-to-revenue, or disclosure of minimum-volume commitments could trigger a sharp reset. Over 6-18 months, model commoditization and declining inference prices are the principal structural risks: revenue can grow rapidly while unit economics deteriorate.

Contrarian view: the IPO may be less a broad AI validation event than a liquidity test for the entire AI complex. A record-scale deal priced aggressively would likely pull forward demand from momentum accounts; a weak aftermarket would pressure high-multiple AI beneficiaries even without a change in their own fundamentals. The article’s financial claims require S-1 verification before assigning a fundamental value or treating projected ARR as investable revenue.

Key Decisions for Investors

• Do not pre-position in the IPO on reported run-rate figures alone; wait for the public S-1 and require quarterly revenue, gross margin, customer concentration, cancellation terms, and minimum compute commitments. Treat any missing disclosure as a no-trade rather than an upside case.
• Maintain NVDA exposure only as a fundamentals-driven AI compute position, not as an IPO sympathy trade. Add only if the S-1 demonstrates that contracted capacity requires incremental accelerator deployment; reduce the event-driven overlay if NVDA rallies materially into listing without corroborating order or supply-chain data.
• For a 1-3 month listing-window risk hedge, consider a modest long QQQ / short high-beta AI-infrastructure basket via SMH relative to QQQ only if the IPO is priced above indicated range and peer EV/sales multiples expand further. Thesis: capital rotation and multiple compression in capex-intensive AI names; exit if the offering prices below range or semiconductor earnings guidance accelerates.
• Set post-filing alerts for gross margin below management-adjusted software peers, compute expense rising faster than revenue for two reported quarters, or disclosed customer concentration above 20%. Any of these would support a bearish post-lockup thesis rather than participation at issuance.
• Avoid treating SPCX as a tradable public-equity read-through absent confirmation of the instrument and contractual counterparty; the claimed infrastructure arrangement is not independently verifiable from the supplied information.